By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Precision BioSciences today announced that it has filed two more patent infringement lawsuits against French firm Cellectis.

The lawsuits were filed in US District Court for the Eastern District of North Carolina and allege Cellectis infringes US Patent Nos. 8,119,381 and 8,119,361. The patents relate to Precision Bio's Directed Nuclease Editor genome engineering technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.